Phibro Animal Health Corporation · NASDAQ:PAHC
Phibro Animal Health — Q2 FY2019 Earnings Presentation
11 slides from Phibro Animal Health's earnings presentation, Feb 7, 2019
Slide 1: Phibro Animal Health Corporation Second Quarter Webcast and Conference Call
Phibro Animal Health Corporation Second Quarter – December 31, 2018 U.S. toll-free +1-877-853-5634 Webcast and Conference Call International toll +1-315-625-6893 February 7, 2019 Conference ID: 8899375
Slide 2: Cautionary Statements
Cautionary Statements Forward-Looking Statements This communication contains forward-looking statements that are subject to risks and uncertainties. All statements other than statements of historical or current fact included in this report are forward-looking statements. Forward-looking statements d
Slide 3: Opening Remarks and Financial Review
Opening Remarks and Financial Review Jack Bendheim Chairman, President, Chief Executive Officer Richard Johnson Chief Financial Officer 3 February 7, 2019 Webcast and Conference Call
Slide 4: GAAP and Non-GAAP Financial Information
GAAP and Non-GAAP Financial Information Reported results are presented in accordance with GAAP Adjusted results are GAAP results adjusted to exclude - Acquisition-related items, including intangible amortization, cost of goods sold, accrued compensation costs, transaction costs and accrued interest
Slide 5: Highlights
Highlights Q2 – December 2018 For the three months ended 2018 2017 Change December 31 (in millions, except per share amounts and percentages) Net sales $ 218.2 $ 205.9 $ 12.3 6% Net income 14.7 7.0 7.7 110% Sales growth across all segments Diluted EPS $ 0.36 $ 0.17 $ 0.19 112% Net income and diluted
Slide 6: Selected Line Items
Selected Line Items Q2 – December 2018 For the three months ended December 31 2018 2017 Change Adjusted gross profit similar to prior year (in millions, except per share amounts and percentages) - Animal Health unfavorable mix and manufacturing costs Net sales $ 218.2 $ 205.9 $ 12.3 6% Adjusted gros
Slide 7: Animal Health
Animal Health Q2 – December 2018 MFAs and other For the three months ended - International sales volume growth in Asia Pacific and Latin 2018 2017 Change December 31 America (in millions, except percentages) - Slight decline in domestic sales MFAs and other $ 93.1 $ 82.0 $ 11.0 13% Nutritional speci
Slide 8: Other Segments
Other Segments Q2 – December 2018 For the three months ended Mineral Nutrition 2018 2017 Change December 31 (in millions, except percentages) – Sales growth from higher average selling prices Mineral Nutrition due to commodity pricing and improved volumes Net sales $ 62.3 $ 59.6 $ 2.7 5% – Adjusted
Slide 9: Capitalization and Capital Allocation
Capitalization and Capital Allocation December 31, 2018 2.5x leverage ratio at December 31, 2018 - $326 million total debt - $128 million LTM Adjusted EBITDA $80 million cash and short-term investments on hand at December 31, 2018 $10 million source of cash before financing and short-term investment
Slide 10: Q&A Session
Q&A Session 10 February 7, 2019 Webcast and Conference Call
Slide 11: © 2019 Phibro Animal Health Corporation, Teaneck, NJ 07666 Phibro; Phibro logo design; Healthy
© 2019 Phibro Animal Health Corporation, Teaneck, NJ 07666 Phibro; Phibro logo design; Healthy Animals. Healthy Food. Healthy World.; and any other Phibro brand or brands shown herein are trademarks owned by or licensed to Phibro Animal Health Corporation or its affiliates. Any other trademark that
Phibro Animal Health — Q2 FY2019 Earnings Presentation on 6ix